Búsqueda en vivo
TopFind está obteniendo las coincidencias más recientes para tu búsqueda.
Revisamos 6 resultados en vivo para herzuma y los redujimos a 3 opciones que parecen valer más la pena comparar primero.
Los temas más fuertes en esta lista son Oncology y Biosimilar.
Fuente: Celltrion Healthcare Singapore Private Limited
Descripción
Herzuma is a trastuzumab biosimilar referencing Herceptin, registered in Singapore for treating HER2-positive breast and gastric cancers. It provides a clinically comparable treatment option that is supported by local health subsidies.
Ideal para
HER2 Positive cancer care, Breast cancer patients y Affordable trastuzumab access
Valoración
Fuente: Celltrion Healthcare Philippines Inc.
Descripción
Herzuma is a biosimilar used in the treatment of HER2-positive cancers, providing a high-quality alternative to reference biologics.
Ideal para
HER2 Positive cancer, Oncology therapy y Biosimilar oncology
Valoración
Fuente: Celltrion Healthcare
Descripción
Herzuma is a biosimilar trastuzumab, a monoclonal antibody designed as a targeted oncology therapy for HER2-positive early breast cancer, metastatic breast cancer, and advanced gastric cancer. It is supplied as a powder for concentrate for solution for infusion in 150mg and 440mg vials.
Ideal para
HER2 Positive breast cancer, Metastatic gastric cancer patients, Cost Effective targeted therapy y Oncology infusion treatment
Valoración
| Comparar | Herzuma | Herzuma (Trastuzumab) | Herzuma (Trastuzumab) |
|---|---|---|---|
| Fuente | Celltrion Healthcare Singapore Private Limited | Celltrion Healthcare Philippines Inc. | Celltrion Healthcare |
| Descripción | Herzuma is a trastuzumab biosimilar referencing Herceptin, registered in Singapore for treating HER2-positive breast and gastric cancers. It provides a clinically comparable treatment option that is supported by local health subsidies. | Herzuma is a biosimilar used in the treatment of HER2-positive cancers, providing a high-quality alternative to reference biologics. | Herzuma is a biosimilar trastuzumab, a monoclonal antibody designed as a targeted oncology therapy for HER2-positive early breast cancer, metastatic breast cancer, and advanced gastric cancer. It is supplied as a powder for concentrate for solution for infusion in 150mg and 440mg vials. |
| Ideal para | HER2 Positive cancer care, Breast cancer patients y Affordable trastuzumab access | HER2 Positive cancer, Oncology therapy y Biosimilar oncology | HER2 Positive breast cancer, Metastatic gastric cancer patients, Cost Effective targeted therapy y Oncology infusion treatment |
| Acción | |||
| Valoración |
Si quieres empezar con la opción más equilibrada, te recomiendo:
"Herzuma de Celltrion Healthcare Singapore Private Limited."
Lo elegí porque Herzuma is a subsidy-eligible trastuzumab biosimilar that ensures affordability and accessibility for breast and gastric cancer patients in Singapore.